Re: Padeliporfin Vascular-Targeted Photodynamic Therapy versus Active Surveillance in Men with Low-Risk Prostate Cancer (CLIN1001 PCM301): An Open-Label, Phase 3, Randomised Controlled Trial

Samir S. Taneja

    Research output: Contribution to journalComment/debatepeer-review

    Original languageEnglish (US)
    Pages (from-to)255-257
    Number of pages3
    JournalThe Journal of urology
    Issue number2
    StatePublished - Aug 1 2017

    ASJC Scopus subject areas

    • Urology

    Cite this